Fate Therapeutics Inc. sell Bank of America Co.
Start price
28.03.24
/
50%
€6.80
Target price
28.03.25
€5.56
Performance (%)
-47.84%
Price
26.04.24
€3.55
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Fate Therapeutics Inc. is performing very well with a performance of -47.84%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Fate Therapeutics Inc. | -21.195% |
iShares Core DAX® | 2.594% |
iShares Nasdaq 100 | 3.553% |
iShares Nikkei 225® | 0.687% |
iShares S&P 500 | 2.209% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat